Cargando…

Failure of high doses of alpha interferon to affect the growth of human carcinoma, melanoma, and myeloid leukaemia xenografts.

Detalles Bibliográficos
Autores principales:	Clutterbuck, R. D., Millar, J. L., Alexander, P.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1983
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011473/ https://www.ncbi.nlm.nih.gov/pubmed/6577906

Ejemplares similares

The response of human myeloid leukaemia xenografts to human recombinant tumour necrosis factor.
por: Clutterbuck, R. D., et al.
Publicado: (1989)

Effects of verapamil and alcohol on blood flow, melphalan uptake and cytotoxicity, in murine fibrosarcomas and human melanoma xenografts.
por: Robinson, B. A., et al.
Publicado: (1986)

Spontaneous regression of human acute myeloid leukaemia xenografts and phenotypic evidence for maturation.
por: Palú, G., et al.
Publicado: (1979)

Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts.
por: Price, G., et al.
Publicado: (1987)

Identification of Monobenzone as a Novel Potential Anti-Acute Myeloid Leukaemia Agent That Inhibits RNR and Suppresses Tumour Growth in Mouse Xenograft Model
por: Dong, Jingwen, et al.
Publicado: (2022)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma.
por: Kruit, W. H., et al.
Publicado: (1996)

The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
por: Bergsagel, D. E., et al.
Publicado: (1990)

Acute myeloid leukaemia relapse presenting as cardiac myeloid sarcoma
por: Waselewski, Alexander, et al.
Publicado: (2018)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Analysis of the multidisciplinary approach for the management of patients affected by chronic myeloid leukaemia
por: Basile, Michele, et al.
Publicado: (2022)

Targeted Mass Spectrometry Reveals Interferon-Dependent Eicosanoid and Fatty Acid Alterations in Chronic Myeloid Leukaemia
por: Scott, Hannah C., et al.
Publicado: (2023)

Interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or Kaposi's sarcoma
Publicado: (2013)

Erythropoiesis in Murine Myeloid Leukaemia
por: Tanaka, T.
Publicado: (1970)

Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
por: Jelliffe, A. M., et al.
Publicado: (1956)

A Case of Myeloid Leukæmia
por: Ghosal, J. N.
Publicado: (1931)

Asciminib for chronic myeloid leukaemia
Publicado: (2022)

Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice
por: Ravaud, A, et al.
Publicado: (1999)

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma
por: Suarez-Kelly, Lorena P., et al.
Publicado: (2019)

CCN3: a key growth regulator in Chronic Myeloid Leukaemia
por: McCallum, Lynn, et al.
Publicado: (2009)

Suchilactone inhibits the growth of acute myeloid leukaemia by inactivating SHP2
por: Wu, Jingjing, et al.
Publicado: (2021)

The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.
por: Twentyman, P. R., et al.
Publicado: (1985)

Human leukaemia: recent tissue culture studies on the nature of myeloid leukaemia.
por: Metcalf, D.
Publicado: (1973)

Evaluation of interferon alpha 2b as adjunctive therapy for conjunctival melanoma
por: Benage, Matthew J., et al.
Publicado: (2019)

Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model
por: Thies, A, et al.
Publicado: (2008)

The dose-response for x-ray induction of myeloid leukaemia in male CBA/H mice.
por: Mole, R. H., et al.
Publicado: (1983)

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
por: Tse, Eric, et al.
Publicado: (2011)

Prevention of acute deaths in mice after very high dose cyclophosphamide by divided dose schedule.
por: Evans, B. D., et al.
Publicado: (1984)

Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)

Adhesion Deregulation in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukaemia
por: Almosailleakh, Marwa, et al.
Publicado: (2019)

Wnt Signalling in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Molecular Mechanisms and Therapies of Myeloid Leukaemia
por: Brown, Elliott, et al.
Publicado: (2022)

Chronic myeloid leukaemia with marked thrombocytosis
por: Ooi, Jun, et al.
Publicado: (2020)

Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts.
por: Kristensen, C. A., et al.
Publicado: (1996)

Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019)

Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence
por: Hampl, Veronika, et al.
Publicado: (2013)

Growth inhibitory effects of interferon on blast cells from patients with acute myelogenous leukaemia.
por: Rohatiner, A. Z.
Publicado: (1984)

PLD-repair in human melanoma xenografts following single dose and fractionated irradiation.
por: Rofstad, E. K.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_qdmbjmr5k5s0ogjja27jebtnf2